Radius Health Shares Information about its Drug RAD011, Upcoming Study in New Fact Sheet

January 24, 2021 — Radius Health, Inc. recently unveiled a detailed fact sheet about its drug RAD011, a synthetic cannabidiol oral solution, which is being studied as a possible treatment for hyperphagia and related behaviors in Prader-Willi syndrome. The fact sheet also gives a description of Radius Health’s upcoming SCOUT-015 clinical trial. According to Radius … Continue reading Radius Health Shares Information about its Drug RAD011, Upcoming Study in New Fact Sheet